Advanced Search

Study Preview



Study Title and Description

Ledipasvir plus sofosbuvir for 12 weeks in patients with hepatitis C genotype 4 infection.



Key Questions Addressed
6 Key Question 6. What is the effectiveness of currently recommended antiviral treatments in improving health outcomes in patients with HCV infection?
  • Comments Comments (
    0
    ) |
7 Key Question 7. What is the effectiveness of currently recommended antiviral treatments in achieving a SVR in patients with HCV infection?
  • Comments Comments (
    0
    ) |
8 Key Question 8. What are the harms of currently recommended antiviral treatments?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Ledipasvir plus sofosbuvir for 12 weeks in patients with hepatitis C genotype 4 infection.
Author Abergel A., Metivier S., Samuel D., Jiang D., Kersey K., Pang PS., Svarovskaia E., Knox SJ., Loustaud-Ratti V., Asselah T.
Country Department of Hepatology and Gastroenterology, Centre Hospitalier Universitaire Estaing, Université d'Auvergne, UMR CNRS 6284, Clermont-Ferrand, France. aabergel@chu-clermontferrand.fr.
Year 2016
Numbers Pubmed ID: 27351341

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Key Questions 1-9


Results & Comparisons

No Results found.